SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-003121
Filing Date
2023-05-10
Accepted
2023-05-10 16:04:47
Documents
50
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT sunshine_i10q-033123.htm   iXBRL 10-Q 572002
2 CERTIFICATION sunshine_ex3101.htm EX-31.1 13522
3 CERTIFICATION sunshine_ex3102.htm EX-31.2 13507
4 CERTIFICATION sunshine_ex3201.htm EX-32.1 5938
5 GRAPHIC image_001.jpg GRAPHIC 6215
6 GRAPHIC image_002.jpg GRAPHIC 12912
  Complete submission text file 0001683168-23-003121.txt   2984731

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE sbfm-20230331.xsd EX-101.SCH 24318
8 XBRL CALCULATION FILE sbfm-20230331_cal.xml EX-101.CAL 43016
9 XBRL DEFINITION FILE sbfm-20230331_def.xml EX-101.DEF 125077
10 XBRL LABEL FILE sbfm-20230331_lab.xml EX-101.LAB 205334
11 XBRL PRESENTATION FILE sbfm-20230331_pre.xml EX-101.PRE 179776
44 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_i10q-033123_htm.xml XML 243053
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41282 | Film No.: 23906263
SIC: 2834 Pharmaceutical Preparations